Connect with us

Bioengineer

Trial of existing antibiotic for treating Staphylococcus aureus Bacteremia begins

NIH-supported trial will test Dalbavancin in hospitalized adultsCredit: NIAID A clinical trial to test the antibiotic dalbavancin for safety and

Published

on

A clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia has begun. The trial will enroll 200 adults hospitalized with complicated S. aureus infection at approximately 20 trial sites around the United States. The trial is being sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

S. aureus is a leading cause of antibiotic-resistant infection. S. aureus infections led to nearly 20,000 deaths in 2017 in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC). This bacterium is of particular concern in healthcare-associated infections. S. aureus bacteremia–an infection of the blood–often requires inserting a central intravenous (IV) catheter to deliver long courses of antibiotics, an invasive procedure that can involve long-term care in healthcare facilities.

“As antibiotic-resistant infections become more widespread, better and easier treatment regimens are needed to ease the burden on both healthcare providers and patients,” said NIAID Director Anthony S. Fauci, M.D. “By investigating existing antibiotics for their action on a broader array of bacterial infections, we may be able to generate new treatment regimens more efficiently.”

The antibiotic dalbavancin has strong activity against gram-positive bacteria, including methicillin-resistant S. aureus, which suggests it could be an effective treatment for S. aureus bacteremia. Dalbavancin is currently FDA-approved in the United States for treating acute bacterial skin and skin structure infections, including those caused by S. aureus. If the two-dose regimen being tested in this trial proves effective, it could lead to a shorter, less invasive treatment for S. aureus bacteremia that does not require an indwelling IV access for daily therapy.

The Phase 2b trial is being conducted by the NIAID-funded Antibacterial Resistance Leadership Group (ARLG) under the leadership of Thomas Holland, M.D., of Duke University (Durham, North Carolina.) It is called the “Dalbavancin as an Option for Treatment of S. aureus Bacteremia (DOTS)” trial. Patients who have stabilized after initial treatment of their bacteremia will be eligible for enrollment in this study.

“Dalbavancin is appealing as a potential option for treatment of these serious S. aureus infections, and we need high quality data to find out if it works,” said Dr. Holland, “This trial will provide clinicians and patients with that data.”

One hundred participants will be randomized to receive the standard of care for complicated infections, including appropriate antibiotics, and 100 participants will receive two doses of dalbavancin intravenously. The doses will be given one week apart. Most participants receiving dalbavancin will be given 1500 milligrams (mg) per dose. Participants with signs of kidney dysfunction will be given 1125 mg per dose. All participants will be followed for approximately 70 days after enrollment, and up to six months if they have vertebral osteomyelitis, an infection of the vertebrae.

At the end of the trial, multiple patient outcomes will be assessed: survival; additional complications (such as relapse) or clinical failures; drug-related adverse events; and overall quality of life. The therapeutic regimen will have met the primary endpoint of the trial if participants who received dalbavancin fare better on these metrics than those who received the current standard of care. This trial could validate a dalbavancin regimen of only one dose a week for two weeks, compared to daily doses administered intravenously for four to six weeks with the current standard of care.

###

The ARLG is a clinical research consortium working to reduce the impact of antimicrobial resistance. It is funded through NIH grant UM1AI104681. For more information about this trial, visit ClinicalTrials.gov and search identifiers NCT04775953.

###

NIAID conducts and supports research–at NIH, throughout the United States, and worldwide–to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIH…Turning Discovery Into Health®

Source: https://bioengineer.org/trial-of-existing-antibiotic-for-treating-staphylococcus-aureus-bacteremia-begins/

trial-of-existing-antibiotic-for-treating-staphylococcus-aureus-bacteremia-begins

Bioengineer

Sex differences in COVID-19 outcomes

Credit: Mary Ann Liebert, Inc., publishers In a study of more than 10,600 adult patients hospitalized with COVID-19, women had

Published

on

In a study of more than 10,600 adult patients hospitalized with COVID-19, women had significantly lower odds than men of in-hospital mortality. They also had fewer admissions to the intensive care unit and less need for mechanical ventilation. Women also had significantly lower odds of major adverse events, including acute cardiac injury, acute kidney injury, and venous thromboembolism, according to an article in the peer-reviewed Journal of Women’s Health. Click here to read the article now.

“This comprehensive analysis is the largest study to date that directly assesses the impact of sex on COVID-19 outcomes,” stated Rachel-Maria Brown, MD, Zucker School of Medicine at Hofstra/Northwell, and coauthors. “Our study strongly demonstrates female sex to be associated with lower odds of in-hospital outcomes, major adverse effects and all-cause mortality as compared to male sex after controlling for confounding variables.” The authors propose some of the protective factors that may contribute to these findings.

In the accompanying editorial entitled “Lessons Learned from COVID-19 Sex Disparities,” Annabelle Santos Volgman, MD, Rush University Medical Center, and coauthors, suggest various mechanisms by which female sex may confer a protective advantage against COVID-19 infection. One advantage may be the extra X chromosome, which carries multiple genes responsible for innate and adaptive immunity.

Volgman and coauthors emphasize that “although women have less mortality risk with COVID-19, we need to exercise caution not to send a message to deliver subpar care to women with COVID-19 or decrease measures to prevent their infection. Our evolving knowledge should not reduce attention paid to women admitted for COVID-19.”

###

Research reported in this publication was supported by the National Institutes of Health under Award Number R24AG064191, R01LM012836, R01 NR018443. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About the Journal

Journal of Women’s Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. Led by Editor-in-Chief Susan G. Kornstein, MD, Executive Director of the Virginia Commonwealth University Institute for Women’s Health, Richmond, VA, the Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women’s healthcare issues. Complete tables of content and a sample issue may be viewed on the Journal of Women’s Health website. Journal of Women’s Health is the official journal of the Society for Women’s Health Research.

About the Publisher

Mary Ann Liebert, Inc., publishers is known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. A complete list of the

Source: https://bioengineer.org/sex-differences-in-covid-19-outcomes/

sex-differences-in-covid-19-outcomes

Continue Reading

Bioengineer

UTHSC awarded $1.5 million HRSA grant for sexual assault nurse examiner training

Credit: UTHSC Memphis, Tenn. (June 16, 2021) – The University of Tennessee Health Science Center’s College of Nursing has received

Published

on

Memphis, Tenn. (June 16, 2021) – The University of Tennessee Health Science Center’s College of Nursing has received a three-year, $1.5 million grant from the Department of Health and Human Services Health Resources and Services Administration (HRSA) to fund a much-needed expansion of Sexual Assault Nurse Examiner (SANE) training and certification in West Tennessee.

SANE programs are designed to train nurses to address survivors’ needs and provide trauma-informed care. The 21 counties of West Tennessee have only five certified SANE nurses, four of whom practice in Shelby County. But the Tennessee Bureau of Investigation received nearly 1,600 reports of sexual assault in West Tennessee in 2019, indicating a significant shortage of nurses certified to meet the need for this care.

Andrea Sebastian, DNP, PNP, SANE-P, an assistant professor in the UTHSC College of Nursing, has worked as a child abuse nurse practitioner for the last seven years at Le Bonheur Children’s Hospital and will serve as project manager of the SANE Training and Education through Partnerships for Underserved Populations (STEP UP) grant.

“During this time, I have recognized the importance of SANE nurses in our community. Currently, we do not have enough SANE nurses in West Tennessee to provide exams and resources to victims,” Dr. Sebastian said. “With this grant, we will be able to increase access to these invaluable resources and help victims of sexual assault in our community.”

The UTHSC team will work with West Tennessee Healthcare, the Shelby County Crime Victims and Rape Crisis Center, and the Whiteville Family Medical Clinic on the project. The team’s goal is to transform the nursing workforce by increasing the supply, distribution, and retention of certified SANEs and improving access to timely, expert care for all sexual assault survivors in West Tennessee.

Assistant Professor Christie Manasco, PhD, RN, is one of the co-investigators on the grant. “The funding from this grant will significantly help us close the gaps to equitable SANE care in West Tennessee. The efforts supported by these funds will help us to reduce inequalities and disparities and promote better outcomes for survivors,” she said.

Beginning in July, the STEP UP grant team will launch a plan to recruit up to 61 registered nurses or advanced practice registered nurses (APRNs) from the West Tennessee counties, with a focus on the rural and underserved areas. The grant will pay for participants to earn certifications through community or academic programs for adult and pediatric patients, known as SANE-A® and SANE-P®.

The grant team will also work with regional stakeholders to develop and implement a regional Sexual Assault Response and Resource Team (SARRT) that will assess the needs for sexual assault services in the area, reduce barriers to SANE training, and coordinate SANE clinical training opportunities. Grant funding also will be used to develop and provide resources for SANE self-care, peer mentoring, continuing education, and recertification.

Dr. Sebastian will be supported on this grant by co-investigators including Dr. Manasco, Assistant Professor Lisa Beasley, DNP, APRN, NP-C, RN; Assistant Professor Sally Humphrey, DNP, ARN, CPNP-PC; and Assistant Professor Diana Dedmon, DNP, FNP-BC, director of Clinical Affairs. College of Nursing Dean Wendy Likes, PhD, DNSc, APRN-Bc, FAANP, will serve as women’s health adviser on the grant, and the program coordinator for the Doctor of Nursing Practice DNP program, Trimika Bowdre, PhD, MPH, will be the evaluation adviser.

“The College of Nursing is very grateful for the funding to support this important work of providing appropriate care to this very vulnerable group of people,” Dr. Likes said. “The need for this in West Tennessee is beyond question. I personally look forward to working with this team in the College of Nursing and our community partners to provide this vital service to our communities.”

###

As Tennessee’s only public, statewide, academic health system, the mission of the University of Tennessee Health Science Center is to bring the benefits of the health sciences to the achievement and maintenance of human health through education, research, clinical care, and public service, with a focus on the citizens of Tennessee and the region. The main campus in Memphis includes six colleges: Dentistry, Graduate Health Sciences, Health Professions, Medicine, Nursing and Pharmacy. UTHSC also educates and trains medicine, pharmacy, and/or health professions students, as well as medical residents and fellows, at major sites in Knoxville, Chattanooga and Nashville. For more information, visit http://www.uthsc.edu. Find us on Facebook: facebook.com/uthsc, on Twitter: twitter.com/uthsc and on Instagram: instagram.com/uthsc.

Source: https://bioengineer.org/uthsc-awarded-1-5-million-hrsa-grant-for-sexual-assault-nurse-examiner-training/

uthsc-awarded-$1.5-million-hrsa-grant-for-sexual-assault-nurse-examiner-training

Continue Reading

Bioengineer

Pioneering chemistry approach could lead to more robust soft electronics

Credit: Udit Chakraborty, Cornell University RESEARCH TRIANGLE PARK, N.C. — A new approach to studying conjugated polymers made it possible

Published

on

RESEARCH TRIANGLE PARK, N.C. — A new approach to studying conjugated polymers made it possible for an Army-funded research team to measure, for the first time, the individual molecules’ mechanical and kinetic properties during polymerization reaction. The insights gained could lead to more flexible and robust soft electronic materials, such as health monitors and soft robotics.

Conjugated polymers are essentially clusters of molecules strung along a backbone that can conduct electrons and absorb light. This makes them a perfect fit for creating soft optoelectronics, such as wearable electronic devices; however, as flexible as they are, these polymers are difficult to study in bulk because they aggregate and fall out from solution.

“Conjugated polymers are a fascinating class of materials due to their inherent optical and electronic properties which are dictated by their polymer structure,” said Dr. Dawanne Poree, program manager, U.S. Army Combat Capabilities Development Command, known as DEVCOM, Army Research Laboratory. “These materials are highly relevant to a number of applications of interest to Army and DoD including portable electronics, wearable devices, sensors, and optical communication systems. To date, unfortunately, it has been difficult to develop conjugated polymers for targeted applications due to a lack of viable tools to study and correlate their structure-property relationships.”

With Army funding, researchers at Cornell University employed an approach they pioneered on other synthetic polymers, called magnetic tweezers, that allowed them to stretch and twist individual molecules of the conjugated polymer polyacetylene. The research was published in the journal Chem.

“Through the use of novel single-molecule manipulation and imaging approaches, this work provided the first observations of single-chain behaviors in conjugated polymers which lays the foundation for the rational design and processing of these materials to enable widespread application,” Poree said.

Previous efforts to address the solubility of conjugated polymers have often relied upon chemical derivatization, in which the structures are modified with functional groups of atoms. However, that approach can affect the polymer’s innate properties.

“The conjugated polymer is really a prototype,” said Dr. Peng Chen, the Peter J.W. Debye professor of chemistry and chemical biology at Cornell. “You always modify it to tailor it for applications. We are hoping everything we measured – the fundamental properties of synthesis kinetics, the mechanical property – become benchmark numbers for people to think about other polymers of the same category.”

In 2017, Chen’s group was the first to use the magnetic tweezers measurement technique to study living polymerization, visualizing it at the single-molecule level. The technique had already been used in the biophysics field for studying DNA and proteins, but no one had successfully extended it to the realm of synthetic polymers.

The process works by affixing one end of a polymer strand to a glass coverslip and the other end to a tiny magnetic particle. The researchers then use a magnetic field to manipulate the conjugated polymer, stretching or twisting it, and measuring the response of a single polymer chain that grows.

The amounts are so small, they stay soluble in solution, the way bulk amounts normally would not.

The team measured how long chains of conjugated polymers, which consist of hundreds of thousands of monomer units, grow in real time. They discovered these polymers add a new monomer per second, a much faster growth than their nonconjugated analogs.

“We found that while growing in real time, this polymer forms conformational entanglements,” Chen said. “All polymers we have studied form conformational entanglements, but for this conjugated polymer this conformational entanglement is looser, allowing it to grow faster.”

By pulling and stretching individual conjugated polymers, so-called force extension measurements, the researchers were able to assess their rigidity and better understand how they can bend in different directions while remaining conjugated and retaining electron conductivity.

They also discovered the polymers displayed diverse mechanical behaviors from one individual chain to the next-behaviors that had been predicted by theory but never observed experimentally.

The findings highlight both the uniqueness of conjugated polymers for a range of applications as well as the strength of using a single-molecule manipulation and imaging technique on synthetic materials.

“Now we have a new way to study how these conjugated polymers are made chemically and what is the fundamental mechanical property of this type of material,” Chen said. “We can study how these fundamental properties change when you start tailoring them for application purposes. Maybe you can make it more mechanically flexible and make the polymer longer, or adjust the synthesis condition to either synthesize the polymer in a faster or slower way.”

###

Visit the laboratory’s Media Center to discover more Army science and technology stories

As the Army’s national research laboratory, ARL is operationalizing science to achieve transformational overmatch. Through collaboration across the command’s core technical competencies, we lead in the discovery, development and delivery of the technology-based capabilities required to make Soldiers more successful at winning the nation’s wars and come home safely. DEVCOM Army Research Laboratory is an element of the U.S. Army Combat Capabilities Development Command. DEVCOM is a major subordinate command of the Army Futures Command.

Source: https://bioengineer.org/pioneering-chemistry-approach-could-lead-to-more-robust-soft-electronics/

pioneering-chemistry-approach-could-lead-to-more-robust-soft-electronics

Continue Reading

Title

Reuters18 hours ago

Eco-friendly sneaker maker Allbirds aims for $2 bln valuation in U.S. IPO

Eco-friendly sneaker maker Allbirds Inc said on Monday it aims to be valued at over $2 billion in its New...

ZDNET2 days ago

Comcast gave me good, precise news. The truth was precisely the opposite

Many companies believe that technology is perfect for customer service communication. Often, though, it just isn't.

Bioengineer5 days ago

Sex differences in COVID-19 outcomes

Credit: Mary Ann Liebert, Inc., publishers In a study of more than 10,600 adult patients hospitalized with COVID-19, women had

Techcrunch6 days ago

Resistant AI scores $16.6M for its anti-fraud fintech tools – TechCrunch

Resistant AI, which uses artificial intelligence to help financial services companies combat fraud and financial crime — selling tools to...

Techcrunch6 days ago

Facebook reportedly plans to change its name to focus on the metaverse – TechCrunch

Facebook is planning to rebrand the company with a new name to focus on building the metaverse, according to a...

Bioengineer1 week ago

UTHSC awarded $1.5 million HRSA grant for sexual assault nurse examiner training

Credit: UTHSC Memphis, Tenn. (June 16, 2021) - The University of Tennessee Health Science Center's College of Nursing has received

Techcrunch1 week ago

Does the NFT craze actually matter? – TechCrunch

Hello friends, and welcome back to Week in Review! Last week, we talked about Apple’s subscription addiction. This week, I’m...

CNBC2 weeks ago

Earnings

Corporate Company Earnings, Find Earnings Per Share and Earnings History Online

ZDNET2 weeks ago

Even computer experts think ending human oversight of AI is a very bad idea

The UK government is thinking of scrapping the right to ask for a human to review decisions made entirely by...

Crunchbase2 weeks ago

The Briefing: Hailo Lands $136M Series C

Crunchbase News' top picks of the news to stay current in the VC and startup world.

Review

    Select language

    Trending